Objective: Little is known about the association between metabolic syndrome (MetSyn), health-related quality of life (HRQoL), and depressive symptoms in hemodialysis (HD) patients. We hypothesized that MetSyn may be associated with lower HRQoL and depression in HD patients.
Design: This was a cross-sectional study.
Setting: The trial involved HD patients at a tertiary-care hospital.
Patients: We evaluated 115 patients (41 women and 74 men; mean age, 48.4 +/- SD 11.9 years SD).
Methods: MetSyn was defined according to National Cholesterol Education Panel criteria. The Medical Outcomes Study Short Form-36 (SF-36) and Beck Depression Inventory (BDI) were used to assess HRQoL and signs of depression, respectively. We compared HRQoL and clinical and psychosocial characteristics among participants with and without MetSyn.
Results: Fifty patients (43.5%) had MetSyn, and 65 patients (56.5%) were free of MetSyn. Comparisons of SF-36 and BDI scores between HD patients with and without MetSyn revealed no statistically significant differences. The Physical Component Summary Score (PCS) of SF-36 was independently associated with HD duration (beta = -0.274, P = .002), age (beta = -0.206, P = .024), sleep disturbance (beta = -0.175, P = .045), albumin (beta = +0.252, P = .006), and hemoglobin (beta = +0.270, P = .002) in stepwise linear regression analysis. The MetSyn was not associated with PCS. The Mental Component Summary Score of SF-36 was independently associated with hemoglobin (beta = +0.235, P = .016) and BDI score (beta = -0.218, P = .025).
Conclusions: The presence of MetSyn was not associated with HRQoL according to the Mental Component Summary Score. In HD patients, HRQoL and depressive behaviors were not influenced by MetSyn, but by various other factors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/j.jrn.2009.01.016 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Metabolic syndrome and associated components among police officers: A 7 and 12-year longitudinal analysis.
J Occup Environ Med
January 2025
Office of the Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA.
Objective: This study estimated risk of metabolic syndrome (MetSyn) and its components among police officers including differences by sex.
Methods: Police officers were examined at baseline and two follow-up examinations after 7 and 12 years. MetSyn was defined using the 2005 guidelines from AHA/NHLBI.
Elevated uric acid level and metabolic syndrome in Non-Hispanic Black American adults.
J Diabetes Metab Disord
June 2025
Department of Population Health Sciences, School of Public Health, Georgia State University, Suite 461 - Urban Life Building, P.O. Box 3984, Atlanta, GA 30302-3984 USA.
Objectives: To ascertain the direct and indirect link between elevated uric acid (eUA) and metabolic syndrome (MetSyn) in Non-Hispanic Black (NHB) American adults.
Design: Structural equation modeling (SEM) was used to disentangle the U.S.
Survival benefit of metformin use according to cancer diagnosis in diabetic patients with metabolic syndrome.
Prev Med Rep
December 2024
Department of Statistics and Actuarial Science, Soongsil University, South Korea.
Background: Metabolic syndrome (MetSyn) is a disease cluster causing cardiovascular disease, cancer, and high mortality. Metformin is the most common antidiabetic agent inhibiting the tumorigenesis and insulin resistance of MetSyn. We describe the association between metformin intake and survival of patients with type 2 diabetes mellitus (T2DM) and MetSyn, according to the presence of cancer.
View Article and Find Full Text PDFMetagenomic Analysis Identifies Sex-Related Gut Microbial Functions and Bacterial Taxa Associated With Skeletal Muscle Mass.
J Cachexia Sarcopenia Muscle
February 2025
Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.
Background: This study aimed to explore the association between gut microbiota functional profiles and skeletal muscle mass, focusing on sex-specific differences in a population under 65 years of age.
Methods: Stool samples from participants were analysed using metagenomic shotgun sequencing. Skeletal muscle mass and skeletal muscle mass index (SMI) were quantified (SMI [%] = total appendage muscle mass [kg]/body weight [kg] × 100) using bioelectrical impedance analysis.
Development of metabolic syndrome in people with Cystic Fibrosis one year after exposure to elexacaftor-tezacaftor-ivacaftor.
J Cyst Fibros
October 2024
Division of Pulmonary and Critical Care, University of Texas Southwestern, Dallas, TX, USA.
Background: The constellation of hypertension, truncal obesity, impaired fasting glucose, low high-density lipoprotein, and hypertriglyceridemia is known as metabolic syndrome (MetSyn) and is associated with cardiovascular and other diseases. Elexacaftor-tezacaftor-ivacaftor (ETI) in people with cystic fibrosis (pwCF) is associated with weight gain but effects on cardiovascular risk are unknown. This study sought to investigate ETI exposure and risk for development of MetSyn in pwCF.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!